Patient Square Bets Big on NKTR: A Deep Dive for Investors
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Learn Which Altcoins Pass Fundamental Test by applying a consistent framework that weighs tech, governance, and economics before investing.
23,646 articlesA prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
A veteran market watcher warns that AI-powered competition is eroding monopoly profits, signaling a brutal reset for ...
As market conditions shift, a 62-year-old engineer’s $1.1 million portfolio illustrates the difficult math of replaci...
As lawmakers push the CLARITY Act to widen the CFTC’s crypto remit, new reporting highlights internal tensions and po...
As Salesforce charts its path to 2027 earnings, investors weigh growth against profitability. This guide breaks down ...
Investors are hearing bold predictions about near-term returns. This article breaks down what Wall Street says stock ...
MARIS has launched a temporary fee waiver for new MLS subscribers, effective through late 2026, in a bid to simplify ...
Suno secures a $400 million round at a $5.4 billion valuation, signaling a shift in how investors view AI-generated m...
A nationwide survey finds 67% of americans fear outliving their money more than death, with Gen X reporting the sharp...
Bitcoin trades near the $63,000 level as a new AI forecast from Microsoft Copilot outlines a 30-day path with a key r...
In 2026, XMAG has surged while MAGS has slipped, underscoring a shift from mega-cap AI bets to broad-market exposure....
June 11 brought a surprising twist: Coupang’s privacy fine landed below feared levels, sending the stock higher and l...